Latest Incentive Plans News

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights significant progress in carbon capture and storage projects and emissions reduction targets.

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, offset by progress in carbon capture and storage projects and emissions reductions. The company posted a net profit of $1.224 billion, down 14% from 2023.

The a2 Milk Company Limited has reported solid revenue and profit growth for the half-year ending December 2024, alongside a confident dividend declaration reflecting its strengthened financial position.

FireFly Metals Ltd reported a reduced half-year loss of A$5.7 million for December 2024, bolstered by a significant increase in cash reserves and strategic asset acquisitions in Canada and Australia.

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

European Metals Holdings has made significant strides in developing its Cinovec Lithium Project, announcing a strategic relocation of its processing plant and ongoing enhancements to production capacity and cost efficiency. The Definitive Feasibility Study is on track for mid-2025 completion, promising a clearer outlook on the project's economic potential.

Althea Group Holdings has obtained Federal Court orders confirming the validity of past share sales despite previous failures to lodge required Cleansing Notices, paving the way for the reinstatement of its shares to trading.

InVert Graphite Limited has secured shareholder approval for a transformative acquisition of a Tanzanian graphite project and rebranded from Dominion Minerals, positioning itself for a strategic relisting on the ASX.

PVW Resources has appointed Lucas Stanfield as CEO, bringing rare earths project expertise to accelerate development of its Brazilian assets. Stanfield’s leadership marks a strategic pivot towards advancing critical mineral projects in a globally significant mining jurisdiction.

Actinogen Medical accelerates recruitment in its pivotal XanaMIA Alzheimer's trial while securing a strong cash position of $22.9 million, underpinning its late-stage development and commercial readiness.

Emyria Limited announces key leadership shifts with Greg Hutchinson stepping up as Executive Chairman and Dr. Michael Winlo transitioning to Chief Scientific Officer, aiming to scale innovative mental health therapies amid growing demand.

Thrive Tribe Technologies has appointed Jade Spooner as CEO to spearhead the rapid commercialisation of its Kumu platform and e-commerce marketplace. Spooner’s proven track record in scaling tech startups positions her to lead 1TT into its next growth phase.